What S&P 500 Returns Without the Magnificent 7 Actually Look Like
Strip Apple, Microsoft, Alphabet, Amazon, Nvidia, Meta, and Tesla out of the S&P 500 and the 2023 headline number collapses. The full index returned 26.3% that year. The remaining 493 stocks returned roughly 8 to 10%. That gap is the whole story, and it has direct implications for how you think about your passive equity exposure right now.
If your portfolio holds a standard cap-weighted S&P 500 index fund, you are running a concentrated bet on seven companies whether you intended to or not.
How Much of the S&P 500 Is Concentrated in the Magnificent 7?
The concentration numbers are stark. According to S&P Dow Jones Indices, the Magnificent 7 collectively represented approximately 30 to 33% of the S&P 500's total market capitalization by late 2024. The top 10 stocks overall accounted for roughly 35% of the index by mid-2024, a level Goldman Sachs Global Investment Research has identified as near 100-year highs.
For context: in a standard S&P 500 index fund, each of these seven stocks carries a weight of roughly 4 to 7%. Every other stock in the index averages around 0.17%.
This is not diversification in any meaningful sense. Standard 60/40 guidance built around the cap-weighted S&P 500 was not written for someone holding $3M in an index fund that is now 30% concentrated in mega-cap tech. The math on tail risk looks very different at that scale.
The technology sector's dominance within the index has compounded this issue. Information technology and communication services combined now represent well over 40% of the cap-weighted index, a sector tilt that happened passively, through price appreciation, not through any active allocation decision by the investor.
S&P 500 Returns Without the Magnificent 7: 2023 and 2024 Data
Morningstar's direct market analysis documented the 2023 split clearly: the S&P 493 delivered single-digit returns while the full index posted 26.3%. That is not a rounding error. It means the average stock in the index had an ordinary year while the headline number implied a banner one.
The table below shows how dramatically the three versions of the index have diverged:
| Year | S&P 500 (Cap-Weight) | S&P 493 (Ex-Mag 7) | S&P 500 Equal Weight |
|---|---|---|---|
| 2019 | +31.5% | ~+27% | +29.2% |
| 2020 | +18.4% | ~+10% | +14.7% |
| 2021 | +28.7% | ~+24% | +30.1% |
| 2022 | -18.1% | ~-12% | -11.6% |
| 2023 | +26.3% | ~+8–10% | +13.8% |
| 2024 | +23–25% (est.) | ~+10–12% (est.) | ~+14% (est.) |
Sources: S&P Dow Jones Indices, Morningstar. S&P 493 figures are approximations derived from index weight and return attribution data. 2024 figures are estimates based on available data through Q3 2024.
The equal-weight index, which assigns identical weight to all 500 constituents, significantly underperformed the cap-weighted version in both 2023 and 2024, according to S&P Dow Jones Indices. That underperformance is entirely attributable to the Magnificent 7's outperformance relative to the rest of the index.
The 5-year market performance analysis tells a similar story: the gap between cap-weighted and equal-weighted returns has widened materially since 2020, tracking the AI-driven surge in mega-cap valuations.
What the S&P 493 Tells You About the Broader Economy
The S&P 493 is a reasonable proxy for the American economy outside of AI and mega-cap tech. Its 8 to 10% return in 2023 is not a bad number. It reflects a functioning economy with reasonable earnings growth across industrials, healthcare, financials, consumer staples, and energy.
What it does not reflect is the AI-driven multiple expansion that inflated the Magnificent 7's valuations. Nvidia's revenue growth was real. But a significant portion of the price appreciation across all seven names in 2023 and 2024 came from multiple expansion, not earnings, as markets priced in AI monetization scenarios that remain speculative.
The sector performance trends outside of tech show a more grounded picture. Healthcare delivered steady mid-single-digit returns. Energy was volatile but positive over the full period. Financials recovered meaningfully after the 2023 regional banking stress. None of these sectors required an AI narrative to justify their valuations.
For investors in the decumulation phase, this distinction matters more than it does during accumulation. Vanguard's 2024 economic outlook explicitly cautioned that elevated valuations concentrated in a narrow band of mega-cap growth stocks increase sequence-of-returns risk for investors relying on portfolio withdrawals. A 30% drawdown in the Magnificent 7 would hit the cap-weighted index far harder than it would hit a broadly diversified or equal-weighted portfolio.
Does Magnificent 7 Dominance Signal an AI Bubble?
The dot-com parallel is not perfect, but it is not dismissible either. Goldman Sachs has noted that the current level of top-10 S&P 500 concentration is near 100-year highs, and that historically, extreme concentration periods have been followed by mean reversion favoring broader market participation. After the dot-com peak in 2000, the equal-weight index outperformed the cap-weighted index for nearly a decade.
The key difference today is earnings. The Nifty Fifty of the 1970s and the dot-com darlings of 1999 were largely priced on hope. The Magnificent 7 are, for the most part, generating real cash flows. Nvidia's data center revenue, Apple's services margin, and Microsoft's Azure growth are not fabrications.
The risk is not that these companies are frauds. The risk is that their current valuations already price in a decade of continued dominance, leaving limited upside and significant downside if AI monetization timelines slip, regulatory pressure intensifies, or a single dominant competitor emerges.
According to Federal Reserve Bank of St. Louis data, U.S. equity market capitalization as a percentage of GDP has reached historically elevated levels, a metric Warren Buffett has cited as a reliable valuation warning signal. That does not mean a crash is imminent. It means the margin of safety is thin.
The S&P 500 versus Nasdaq performance comparison illustrates how correlated the cap-weighted S&P 500 has become with what was once a distinctly tech-heavy index. Owning both no longer provides the diversification it once did.
Concentration Risk by the Numbers: What $5M+ Portfolios Actually Look Like
| Strategy | Mag 7 Allocation | Single-Stock Max Weight | Sector Concentration (Tech + Comm) |
|---|---|---|---|
| Cap-weight S&P 500 | ~30–33% | ~7% (Apple/Microsoft) | ~42% |
| Equal-weight S&P 500 (RSP) | ~1.4% (7 × 0.2%) | ~0.2% | ~14% |
| Fundamental-weight (RAFI) | ~10–15% | ~2–3% | ~20–25% |
| S&P 500 Quality Index | ~20–25% | ~4–5% | ~30–35% |
| Custom 60/40 with int'l equity | ~12–18% | ~3–4% | ~18–22% |
Sources: S&P Dow Jones Indices, Research Affiliates, Invesco. Allocations are approximate and shift with market prices.
Research published in the Journal of Financial Planning found that portfolios with more than 25% concentration in a single sector face materially higher probability of shortfall over 30-year retirement horizons, even when historical sector returns have been strong. A cap-weighted S&P 500 fund currently sits above that threshold on tech and communication services combined.
The Schwab Center for Financial Research has documented that investors who maintained diversified sector exposure rather than chasing concentrated winners historically achieved more consistent risk-adjusted returns over full market cycles. Consistent is the operative word for someone in or near decumulation.
Tax-Efficient Ways to Reduce Magnificent 7 Concentration
This is where the conversation gets specific to FatFIRE-level portfolios. If you accumulated Apple, Microsoft, or Nvidia in a taxable account during the 2010s bull market, you are sitting on unrealized gains that can make straightforward rebalancing prohibitively expensive. A $2M position with a $200K cost basis does not get trimmed casually.
Several tools exist for this situation:
Charitable Remainder Trusts (CRTs). A CRT allows you to transfer appreciated shares into the trust, which then sells them tax-free and reinvests in diversified assets. You receive an income stream, a partial charitable deduction, and the remainder passes to your designated charity. It simultaneously addresses concentration risk, provides current income, and serves philanthropic goals. The tradeoff is irrevocability and the charitable component.
Donor-Advised Funds (DAFs). For smaller positions or partial diversification, contributing appreciated shares directly to a DAF generates a fair-market-value charitable deduction in the year of contribution, avoids capital gains on the appreciation, and allows the DAF to sell and reinvest without tax drag. You retain advisory privileges over grant-making.
Exchange Funds. Accredited investors can contribute appreciated stock to an exchange fund alongside other investors contributing different concentrated positions. After a holding period (typically seven years), you receive a diversified basket of stocks. No immediate capital gains are triggered. Access is generally limited to investors with $1M+ in a single position.
Tax-Loss Harvesting Offsets. IRS Publication 550 governs wash-sale rules and long-term capital gains treatment. If you have losses elsewhere in the portfolio, harvesting them to offset Magnificent 7 gains can reduce the net tax cost of rebalancing. This is most effective in years with significant portfolio volatility, which the current environment periodically provides.
Installment Sales and Opportunity Zone Investments. For very large positions, spreading gains across tax years through installment structures, or deferring gains through Qualified Opportunity Zone investments, can reduce the effective tax rate on diversification.
None of these strategies is simple to implement without a tax attorney and a financial advisor who understands concentrated positions. But the cost of inaction, holding 30%+ of a $5M portfolio in seven names through a potential mean-reversion cycle, can exceed the tax cost of diversifying.
Alternative Index Strategies Worth Considering
The S&P 500 Equal Weight ETF (ticker: RSP, managed by Invesco) assigns approximately 0.2% to each constituent, reducing Magnificent 7 exposure to roughly 1.4% total versus 30%+ in the cap-weighted version. The tradeoff is a small-cap tilt (equal-weighting mechanically overweights smaller companies within the index) and historically higher turnover.
Fundamentally-weighted indices, such as those constructed by Research Affiliates using the RAFI methodology, weight constituents by economic fundamentals (revenue, cash flow, dividends, book value) rather than market price. This approach mechanically reduces exposure to overvalued mega-caps and increases exposure to value-oriented names. It has historically outperformed cap-weighting over full cycles, though it underperformed significantly during the 2017 to 2024 growth-dominated period.
The quality index alternatives within the S&P family screen for high return on equity, stable earnings, and low financial leverage. These indices tend to have meaningful Magnificent 7 exposure (quality screens favor profitable companies with strong balance sheets) but at lower weights than the cap-weighted index.
For FatFIRE investors who want to maintain broad U.S. equity exposure without making active sector bets, a blend of cap-weighted and equal-weighted exposure (say, 50/50) cuts Magnificent 7 concentration roughly in half while preserving most of the liquidity and low-cost characteristics of index investing.
The S&P 500 versus total market index comparison is also worth reviewing. The total market adds small and mid-cap exposure, which further dilutes mega-cap concentration and historically provides a return premium over full cycles.
Sector Opportunities in the S&P 493
Removing the Magnificent 7 from the analysis reveals sectors that have been structurally underweighted in most passive portfolios despite reasonable fundamentals.
Financials. The financial sector opportunities within the S&P 500 include major banks, insurance companies, and asset managers that trade at significantly lower multiples than the Magnificent 7. After the 2023 regional banking stress resolved without systemic contagion, large-cap financials recovered and offer dividend yields that tech stocks do not.
Healthcare. Biotech and pharmaceutical names within the S&P 493 carry pipeline optionality that is not reflected in current valuations. The sector's weight in the cap-weighted index has declined as tech's weight expanded, creating a relative underweight in most passive portfolios.
Industrials and Energy. The infrastructure spending cycle, reshoring of manufacturing, and energy transition capital expenditure represent multi-year tailwinds for companies in these sectors. They appear in the S&P 493 at reasonable valuations and have low correlation to AI-driven tech narratives.
The how sector weights have shifted over the past decade illustrates how mechanically passive investing in the cap-weighted index has reduced exposure to these sectors without any active decision by the investor.
Portfolio Construction Implications for High-Net-Worth Investors
The practical question is what to do with this analysis. A few frameworks worth considering:
Concentration audit. Add up your total exposure to the Magnificent 7 across all accounts, including index funds, direct holdings, and any tech-heavy active funds. If the combined weight exceeds 25 to 30% of your equity portfolio, you are running sector concentration risk that the Journal of Financial Planning research suggests meaningfully increases shortfall probability over 30-year horizons.
Rebalancing threshold. Set a maximum weight for any single sector (tech plus communication services combined) at 25 to 30% of your equity allocation. When the cap-weighted index pushes you above that threshold through price appreciation, rebalance systematically rather than reactively.
Tax-year planning. Coordinate Magnificent 7 rebalancing with tax-loss harvesting opportunities elsewhere in the portfolio. Your tax attorney should model the after-tax cost of rebalancing versus the risk-adjusted cost of holding the concentration.
International diversification. Non-U.S. developed market equities (MSCI EAFE) and emerging markets carry minimal Magnificent 7 exposure by definition. Adding international equity reduces overall portfolio concentration in U.S. mega-cap tech without requiring you to make a directional call on any individual stock.
The historical S&P 500 returns data shows that the index has delivered strong long-term returns across many different concentration regimes. The question is not whether to own U.S. equities. The question is whether your current allocation reflects a conscious decision about Magnificent 7 exposure or an accidental one made by default through passive indexing.
Comparing Concentration Risk Reduction Strategies
| Strategy | Tax Efficiency | Complexity | Minimum Size | Maintains Equity Upside |
|---|---|---|---|---|
| Equal-weight index (RSP) | High (ETF structure) | Low | Any | Yes (broad U.S. equity) |
| Fundamental-weight (RAFI) | High | Low | Any | Yes (value-tilted) |
| Exchange fund | High (deferred gains) | High | $1M+ per position | Yes (diversified basket) |
| Charitable Remainder Trust | High (tax-free sale) | Very high | $500K+ | Partial (income stream) |
| Donor-Advised Fund | High (deduction + no cap gains) | Medium | Any | No (charitable) |
| Tax-loss harvest + rebalance | Medium | Medium | Any | Yes |
| Installment sale + OZ investment | Medium-high | High | $1M+ | Partial (OZ exposure) |
This table is illustrative. Tax treatment depends on individual circumstances. Consult a qualified tax attorney before implementing.
The top companies by revenue analysis provides additional context on which Magnificent 7 names carry the most fundamental justification for their valuations versus which are most exposed to multiple compression if AI timelines disappoint.
The Magnificent 7 ETF options available through major fund families allow investors to take a deliberate, sized position in these names rather than inheriting an unintended 30% allocation through passive indexing. That reframing, from accidental concentration to intentional allocation, is the core shift this analysis argues for.
The S&P 493's 8 to 10% return in 2023 was not a failure. It was a reasonable return from a diversified set of American businesses. The problem is that most investors did not know that was what they were getting, because the headline number said 26.3%.
References
- S&P Dow Jones Indices -- "S&P 500 Equal Weight Index Fact Sheet" (2024)
- S&P Dow Jones Indices -- "S&P 500 Index Methodology and Constituent Weights" (2024)
- Morningstar -- "Morningstar Direct: U.S. Market Concentration and Factor Analysis" (2024)
- Vanguard -- "Vanguard Economic and Market Outlook 2024: A Return to Sound Money" (2024)
- Federal Reserve Bank of St. Louis (FRED) -- "Market Capitalization of Listed Domestic Companies (% of GDP) - United States" (2024)
- Journal of Financial Planning -- "Concentration Risk and Portfolio Longevity in High-Net-Worth Retirement Portfolios" (2023)
- IRS -- "Publication 550: Investment Income and Expenses" (2024)
- Goldman Sachs Global Investment Research -- "S&P 500 Concentration: Historical Parallels and Forward Return Implications" (2024)
- Schwab Center for Financial Research -- "The Case for Diversification: Sector Concentration and Long-Term Returns" (2023)
